MELLONE, MANUELA

MELLONE, MANUELA  

Dipartimento di Scienze Farmacologiche e Biomolecolari  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure. 2020 Palese FMellone MZianni EScheggia DMarcello EDi Luca MGardoni F. + Article (author) -
Linking NMDA Receptor Synaptic Retention to Synaptic Plasticity and Cognition 2019 Franchini, LucaStanic, JenniferPonzoni, LuisaMellone, ManuelaCarrano, NicolòMusardo, StefanoZianni, ElisaMarcello, ElenaSala, MariaelvinaDi Luca, MonicaGardoni, Fabrizio + Article (author) -
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 2019 Mellone, ManuelaGardoni, Fabrizio + Article (author) -
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology 2019 M. MelloneE. ZianniJ. StanicA. LonghiM. Di LucaF. Gardoni + Article (author) -
Safinamide modulates striatal glutamatergic signalling in a rat model of levodopa-induced dyskinesia 2018 F. GardoniM. Mellone + Article (author) -
Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target 2018 J. StanicM. MelloneE. ZianniM. Di LucaF. Gardoni + Article (author) -
Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications 2018 Manuela MelloneFabrizio Gardoni Article (author) -
Rabphilin 3A : a novel target for the treatment of levodopa-induced dyskinesias 2017 Stanic, JenniferMellone, ManuelaZianni, ElisaMinocci, DaianaLonghi, AnnalisaDi Luca, MonicaGardoni, Fabrizio + Article (author) -
Anti-AMPA GluA3 antibodies in Frontotemporal dementia: A new molecular target 2017 J. StanicM. MelloneE. ZianniM. Di LucaF. Gardoni + Article (author) -
LRRK2 phosphorylation level correlates with abnormal motor behaviour in an experimental model of levodopa-induced dyskinesias 2016 J. StanicM. MelloneE. ZianniM.M.G. Di LucaF. Gardoni + Article (author) -
Ring finger protein 10 is a novel synaptonuclear messenger encoding activation of NMDA receptors in hippocampus 2016 N. MitroS. MusardoM. MelloneE. MarcelloJ. StanicT. SamaddarF. GardoniM.M.G. Di Luca + Article (author) -
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia : Behavioral, molecular, and synaptic mechanisms 2016 M. MelloneJ. StanicF. Gardoni + Article (author) -
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 2016 F. GardoniM. Mellone + Article (author) -
Zinc transporter-1: a novel NMDA receptor-binding protein at the postsynaptic density 2015 M. MelloneS. PelucchiM. Di LucaF. Gardoni + Article (author) -
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease 2015 M. MelloneF. Gardoni + Article (author) -
NMDA receptor gluN2A/gluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias : from experimental models to patients 2015 M. MelloneJ. StanicE. ZianniA. LonghiM. Di LucaF. Gardoni + Article (author) -
Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies 2013 M. Mellone + Article (author) -
Modulation of NMDA receptor at the synapse: Promising therapeutic interventions in disorders of the nervous system 2013 M. MelloneF. Gardoni Article (author) -
Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine : implications for reparative therapy in Parkinson's disease 2012 P. BossolascoM. MelloneC. CalzarossaG. Lambertenghi-DeliliersV. Silani + Article (author) -
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat 2010 P. BossolascoC. CalzarossaM. MelloneG. BuscaG. Lambertenghi DeliliersV. Silani + Article (author) -